Caudal Dexamethasone - Bupivacaine in Neonates

ConditionWe Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age1-28

SponsorAin Shams University

About this trial

Randomied controlled study Evaluate the effects of caudal Dexamethasone in neonates

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

full term neonate

ASA I & ASA II

Scheduled for inguinal hernia repair

Disqualifiers

Patients with allergies to studied drugs

body weight <3 kilograms

parents refusal

Trial design

Design model

Parallel

Treatments tested in this trial

We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonsates undergoing inguinal hernia repair in Dexamethasone - Bupivacaine group
Procedure/Surgery
We add Dexamethasone to Bupivacaine as adjuvant to Bupivacaine in neonates undergoing inguinal hernia repair

Treatment groups

150 Participants

are divided into 2 treatment groups

Group A: Dexamethasone - Bupivacaine groupActive comparator 1 intervention

Group B: Saline - Bupivacaine groupOther 1 intervention

Trial outcomes

Primary outcomes

FLACC pain scale (face,leg , activity,cry, consolability) in the first 24 hours postoperative

Assessment for additive analgesic effects of caudal Dexamethasone

Time frame

6 months

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: